Ignacio Garrido-Laguna, MD
Assistant Professor, University of Utah School of Medicine
Ignacio Garrido-Laguna, MD is an assistant professor of oncology at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI) investigator. At HCI, he sees patients with gastrointestinal cancers and patients enrolled in Phase I trials.
At HCI, Garrido-Laguna’s primary research interest is pancreatic ductal adenocarcinoma (PDA), which is the most common form of pancreatic cancer. Through his research, he has found that stroma (tissue around the tumor that gives nutrition to cancer cells) is involved in resistance to chemotherapy. He and his lab are expanding their research in order to understand what role stroma plays and what drugs can stop its negative reaction to the therapy. They intend to use this information to help identify more effective treatments for PDA.
Before joining HCI, Garrido-Laguna was a clinical fellow in the Phase I program at the University of Texas MD Anderson Cancer Center. He completed his postdoctoral fellowship in the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Garrido-Laguna finished his internship and residency in medical oncology at Hospital Universitario 12 de Octubre in Madrid, Spain. Garrido-Laguna received his medical degree from the School of Medicine of Universidad de Navarra, Pamplona, Spain.